DOTmed March 24, 2025
Johnson & Johnson plans to invest more than $55 billion in U.S.-based manufacturing, research and development, and technology initiatives through 2028—a 25% increase over the company’s previous four-year domestic investment.
The New Brunswick, New Jersey-based healthcare firm broke ground Thursday on a new biologics manufacturing facility in Wilson, North Carolina. The $2 billion project will span 500,000 square feet and is expected to support roughly 5,000 construction jobs and add more than 500 full-time positions upon completion. Company estimates suggest the site will generate $3 billion in economic impact across North Carolina in its first decade of operations.
The Wilson plant is one of four new advanced manufacturing facilities Johnson & Johnson plans to open in the coming years. Additional...
Today's Sponsors
Today's Sponsor